Opus Genetics, Inc. · NASDAQ:IRD
Balyasny Asset Management L.P. reported a 7.41% stake in Opus Genetics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 17, 2026
Balyasny Asset Management L.P. reported a 7.41% stake in Opus Genetics, Inc., 5,110,373 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 7.41%
- Shares
- 5,110,373
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Balyasny Asset Management L.P. | 7.41% | 5,110,373 |
| BAM GP LLC | 7.41% | 5,110,373 |
| Balyasny Asset Management Holdings LP | 7.41% | 5,110,373 |
| Dames GP LLC | 7.41% | 5,110,373 |
| Dmitry Balyasny | 7.41% | 5,110,373 |
Source
Related
- Opus Genetics, Inc.
- Balyasny Asset Management L.P.
- Opus Genetics, Inc. shareholders
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · May 15, 2026
- Form 4 · Foundation Fighting Blindness Retinal Degeneration Fund · Oct 2, 2026
- Form 4 · Magrath George · Sep 11, 2026
- Form 4 · Gallagher Cam · Sep 8, 2026
- Form 4 · Gagnon Robert E. · Sep 8, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026